Journal article
Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline
Abstract
BACKGROUND AND PURPOSE: Covert brain infarcts are associated with cognitive decline. It is not known whether therapies that prevent symptomatic stroke prevent covert infarcts. COMPASS compared rivaroxaban with and without aspirin with aspirin for the prevention of stroke, myocardial infarction, and vascular death in participants with stable vascular disease and was terminated early because of benefits of rivaroxaban 2.5 mg twice daily plus …
Authors
Sharma M; Hart RG; Smith EE; Bosch J; Eikelboom JW; Connolly SJ; Dyal L; Reeh KW; Casanova A; Diaz R
Journal
Stroke, Vol. 51, No. 10, pp. 2901–2909
Publisher
Wolters Kluwer
Publication Date
10 2020
DOI
10.1161/strokeaha.120.029762
ISSN
0039-2499